Delivery Order SPE2DB22D3016-SPE2DB24FAQE4
Award Date
3/18/24
Potential Completion Date
3/19/24
Potential Value
$3.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract, valued at $5,107.02, is a firm fixed price delivery order for the supply of the pharmaceutical product Briviact 50 mg tablets. The contract has an ultimate completion date of April 5, 2024. Amerisourcebergen Drug Corp is also the prime contractor on a larger $999,999,999.00...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the pharmaceutical product Briviact 75 mg tablets. The $1,756.86 delivery order contract is a Firm Fixed Price arrangement with the Defense Logistics Agency (DLA) Troop Support Medical. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical and medical supplies to support the Department of...
The U.S. Defense Logistics Agency (DLA) awarded a $2,621.01 delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of 100mg Briviact tablets, a prescription medication, with a performance period through May 14, 2024. Amerisourcebergen is a major supplier of pharmaceuticals and medical supplies to various federal agencies, especially the Department of Defense (DoD) and Department of Veterans...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,145.15 firm fixed-price delivery order is for the supply of 4,568,231,618 tablets of the medication Briviact 50 mg. The contract has an ultimate completion date of May 14, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,625.19 firm fixed price delivery order is for the supply of 60 tablets of the prescription medication BRIVIACT 100 MG. The contract has an ultimate completion date of June 11, 2025 and is not set-aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC)...
This federal contract award is to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award, valued at $1,674.55, is a firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to supply Briviact 100 mg tablets. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00, which serves as the primary...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division to provide the pharmaceutical product Briviact 50 mg tablet. The contract has a ceiling value of $2,553.51 and a completion date of April 22, 2024. Amerisourcebergen is a major supplier of pharmaceuticals and medical supplies to the federal government, with a focus on serving the Department of Defense (DoD) and Veterans Affairs (VA) healthcare...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a pharmaceutical distribution subsidiary of Amerisourcebergen Corporation. The $1,705.58 firm fixed-price contract is for the supply of Briviact 10 mg/ml oral solution in 300 ml bottles, with a period of performance through May 13, 2024. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Briviact 25 mg tablets. The contract, valued at $2,484.06, is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The $11,595.24 firm fixed-price delivery order is for the supply of Briviact 50 mg tablets, a pharmaceutical product. The contract has an ultimate completion date of August 28, 2024 and is not designated as a set-aside. AmerisourceBergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with...